Amount Raised
€5.4 Million
Round Type
Seed
AachenBiotechnologyHealth CareDescription
Vivalyx has secured €5.4M in Seed round funding. The money will be used to finance necessary clinical trials for regulatory clearance and to start commercialization of their preservation liquid for optimal organ preservation before transplant.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Vivalyx that raised within 45 days of this round, from Fundz verified event records.
- Hubly raised $1.3M on June 14, 2024.
- Novabay raised $226K on June 14, 2024.
- UPyTher raised $1.5M (Seed) on June 13, 2024.
- InduPro raised $85M (Series A) on June 13, 2024.
- Sova Health raised $1M (Seed) on June 11, 2024.
- Moleculent AB raised $26M (Series A) on June 11, 2024.
Who to call at Vivalyx, and when
A new round usually means Vivalyx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vivalyx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vivalyx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vivalyx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vivalyx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Vivalyx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.